Even though the reason for the decreased muscle carnosine content only in type 2 diabetes remains unclear, this may explain the differences observed in genetic studies regarding polymorphisms in the CNDP1 gene, which encodes CN1. This evidence concerns the gene CNDP1 and type 2 diabetes mellitus.